Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 138 entries
View as:

Study to Evaluate the Efficacy and Safety of HX575 Hexal AG vs ERYPO® for the Treatment of Anemia in Hemodialysis Patients

Phase: N/A Priority: Normal
NCT ID: NCT00666835 Org: User:
Start: 04/30/04 End: 01/31/06 Due: 01/31/07

A Pilot Trial Evaluating an Alternating Schedule of Recombinant Human GM-CSF and Azidothymidine in Patients With HIV Infection and Leukopenia

Phase: N/A Priority: Normal
NCT ID: NCT00002007 Org: User:
Start: - End: - Due: -

A Study Comparing the Clinical Equivalence of Two Mometasone Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT01038427 Org: User:
Start: 12/02/09 End: 02/16/10 Due: 02/16/11

To Demonstrate the Relative Bioequivalency Comparing Geneva's 10 mg Glipizide Tablets To Roerig's 10 mg Glucotrol Tablets

Phase: N/A Priority: Normal
NCT ID: NCT00946504 Org: User:
Start: 10/31/92 End: 10/31/92 Due: 10/31/93

In Vivo Performance of Oral Liquid Formulations of Budesonide in the Fasted State in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05429775 Org: User:
Start: 12/26/18 End: 01/29/19 Due: 01/29/20

To Demonstrate the Relative Bioavailability of Bupropion HCI 300 mg Extended-Release Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00861939 Org: User:
Start: 03/31/04 End: 04/30/04 Due: 04/30/05

To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00946686 Org: User:
Start: 09/30/02 End: 09/30/02 Due: 09/30/03

To Demonstrate the Relative Bioavailability of Divalproex Sodium 500 mg Delayed Release Tablets Under Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00913848 Org: User:
Start: 10/31/05 End: 10/31/05 Due: 10/31/06

Bioequivalence Study of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00864006 Org: User:
Start: 10/31/06 End: 10/31/06 Due: 10/31/07

Relative Bioavailability Study of Ribavirin 200 Capsules and Rebetol 200 mg Capsules in Females Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00960479 Org: User:
Start: 01/31/01 End: 02/28/01 Due: 02/28/02

To Demonstrate the Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00946465 Org: User:
Start: 10/31/04 End: 11/30/04 Due: 11/30/05

Relative Bioavailability Study of Bicalutamide 50 mg Tablet and Casodex Following a 50 mg Dose in Healthy Subjects Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00959335 Org: User:
Start: 08/31/06 End: 08/31/06 Due: 08/31/07

Real-world Study of Anti-TNFa Treatment Regimes of Hyrimoz or Zessly in Patients With Crohn´s Disease

Phase: N/A Priority: Normal
NCT ID: NCT03890445 Org: User:
Start: 06/24/19 End: 05/08/20 Due: 05/08/21

Pramipexole and Bromocriptine on Nonmotor Symptoms of Early Parkinson's Disease

Phase: N/A Priority: Normal
NCT ID: NCT01673724 Org: User:
Start: 02/29/12 End: 05/23/16 Due: 05/23/17

Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients.

Phase: N/A Priority: Normal
NCT ID: NCT03978494 Org: User:
Start: 09/02/19 End: 05/03/20 Due: 05/03/21

Non-interventional-study With Tacrolimus Sandoz© Capsules for Prophylaxis of Renal Graft Rejection

Phase: N/A Priority: Normal
NCT ID: NCT01353417 Org: User:
Start: 04/30/11 End: 08/31/15 Due: 08/31/16

To Demonstrate the Relative Bioequivalence of Cefdinir and Omnicel 250 mg/5 ml Oral Suspension Fed Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00883883 Org: User:
Start: 04/30/05 End: 05/31/05 Due: 05/31/06

Study to Evaluate the Efficacy, Safety and Immunogenicity of Subcutaneous HX575 in the Treatment of Anemia Associated With Chronic Kidney Disease (SWEEP)

Phase: N/A Priority: Normal
NCT ID: NCT00869856 Org: User:
Start: 04/30/09 End: 08/31/09 Due: 08/31/10

A Pilot Study to Evaluate the Effects of Subcutaneously Administered Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor in Pediatric HIV-Infected Patients With Neutropenia Secondary to Azidothymidine

Phase: N/A Priority: Normal
NCT ID: NCT00002263 Org: User:
Start: - End: - Due: -

Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02638259 Org: User:
Start: 02/21/15 End: 06/12/17 Due: 06/12/18

Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa

Phase: N/A Priority: Normal
NCT ID: NCT01693029 Org: User:
Start: 09/30/12 End: 03/31/15 Due: 03/31/16

Phase III Study Assessing the Efficacy, Safety and Immunogenicity of SOK583A1 Versus Eylea® in Patients With Neovascular Age-related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT04864834 Org: User:
Start: 05/12/21 End: 05/10/23 Due: 05/10/24

Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational Age

Phase: N/A Priority: Normal
NCT ID: NCT01491854 Org: User:
Start: 07/20/09 End: 10/31/18 Due: 10/31/19

Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Adalimumab (GP2017) and Humira

Phase: N/A Priority: Normal
NCT ID: NCT02016105 Org: User:
Start: 12/31/13 End: 02/29/16 Due: 02/28/17

To Demonstrate the Relative Bioavailability Study of Promethazine HCl 50 mg Tablets Under Fasting Conditions

Phase: N/A Priority: Normal
NCT ID: NCT00947063 Org: User:
Start: 07/31/04 End: 08/31/04 Due: 08/31/05